Health / Medical Topics

    Bivalent HPV16/18 Therapeutic Cervical Cancer Vaccine

    A bivalent human papillomavirus (HPV) therapeutic vaccine containing recombinant inactivated adenylate cyclase (CyaA) from Bordetella pertussis carrying a sequence encoding the E7 antigen of both HPV16 and 18, with potential immunostimulatory and antiviral properties. Upon administration of bivalent HPV16/18 therapeutic cervical cancer vaccine, the expressed proteins may activate cell-mediated immunity and induce both cytotoxic CD8+ T cells and CD4+ helper T cells against the target antigens HPV16-E7 and HPV18-E7, which leads to HPV viral clearance. Adenylate cyclase is a virulence factor of Bordetella pertussis. Its ability to bind to CD11b-expressing dendritic cells and deliver antigens directly to the cytosol allows the activation and induction of T-cell immunity. CyaA may also induce a B cell response. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    Bitter Fennel Fruit Oil
    The oil extracted from the fruit of Foeniculum vulgare. Bitter fennel fruit oil can be used as treatment for digestive complaints. …
    Bitter Almond Oil
    The oil extracted from the seed press-cake of Prunus amygdalus var. amara. Bitter almond oil is used as a flavoring and…
    Bitolterol Mesylate
    The mesylate salt of bitolterol, a diester sympathomimetic amine with bronchodilator activity. As an ester prodrug, bitolterol is hydrolyzed by esterases to…
    Bitolterol
    A diester sympathomimetic amine with bronchodilator activity. As an ester prodrug, bitolterol is hydrolyzed by esterases to its active metabolite colterol…
    Bitmask
    A binary number in which a bit is set to either on or off to store information for bitwise operations.
    Biting Capsule Dosage Form
    A capsule designed to be bitten to release the active and/or inert ingredient(s).

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact